Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction*

Title
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction*
Authors
Keywords
-
Journal
CRITICAL CARE MEDICINE
Volume 36, Issue 8, Pages 2257-2266
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2009-03-06
DOI
10.1097/ccm.0b013e3181809846

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started